This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Roche Diagnostics Operations, Inc.. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: The Innovative Contributions of Marcus Schmid
Introduction
Marcus Schmid is a notable inventor based in Wessobrunn, Germany. He has made significant contributions to the field of nucleic acid purification. His work has implications for various scientific and medical applications.
Latest Patents
Marcus Schmid holds a patent for the "Use of TDE for isolation of nucleic acids." This invention provides the use of tetraethylene glycol dimethyl ether for adsorbing nucleic acids to solid phases, such as those with silica surfaces. The patent also includes compositions comprising TDE and methods for purifying nucleic acids from samples. Notably, the invention encompasses methods for the purification of low molecular weight nucleic acids, which are suited for assays aimed at detecting target nucleic acids. He has 1 patent to his name.
Career Highlights
Throughout his career, Marcus Schmid has worked with prominent companies in the diagnostics field. He has been associated with Roche Diagnostics Operations, Inc. and Roche Diagnostics GmbH. His experience in these organizations has contributed to his expertise in the development of innovative solutions for nucleic acid purification.
Collaborations
Marcus Schmid has collaborated with notable professionals in his field, including Frank Bergmann and Manfred Watzele. These collaborations have likely enriched his work and contributed to the advancements in nucleic acid purification technologies.
Conclusion
Marcus Schmid's contributions to the field of nucleic acid purification through his innovative patent demonstrate his commitment to advancing scientific research. His work continues to have a lasting impact on the industry.